
Scabies
Epidemiology & Risk Factors
Prevalent worldwide, higher in crowded settings (aged care, institutions, remote Aboriginal & Torres Strait Islander communities)
High-risk: Children, immunocompromised, elderly in care
Outbreaks common in schools, long-term care facilities, prisons
Clinical Features
Classic (Typical) Scabies
Intense nocturnal pruritus
Burrows: short, wavy, greyish lines (web spaces, wrists, waist, buttocks, genital area)
Polymorphic rash: papules, vesicles, nodules, excoriations
Crusted (Norwegian) Scabies
Highly contagious, occurs in immunocompromised/neurologically impaired patients
Thick, hyperkeratotic crusts (massive mite burden)
Minimal pruritus, but highly infectious → public health concern, notifiable in some Australian states
Scabies in Infants & Young Children
Can involve head, neck, palms, soles
Widespread vesiculopustular lesions or eczema-like changes
Nodular scabies: persistent nodules (groin, axillae)
Diagnosis
Clinical diagnosis: Night-time pruritus, household contacts with similar symptoms, presence of burrows/papules
Microscopy of skin scrapings (definitive but not always needed)
Delayed diagnosis common (subtle/atypical presentation in elderly, immunocompromised)
Differential Diagnoses
Eczema, papular urticaria (insect bites), contact dermatitis
Tinea (dermatophyte infection), psoriasis (less common)
Complications
Secondary bacterial infection: S. aureus, S. pyogenes → impetigo, cellulitis
In remote settings, can lead to acute rheumatic fever, post-streptococcal glomerulonephritis
Crusted scabies: High mite burden → risk of bacteraemia, ulceration, outbreaks
Management
General Measures
Treat all close contacts (household, sexual partners) simultaneously
Linen/clothing: Wash hot (≥60°C) or seal in plastic bag for ≥8 days
Vacuum furniture, carpets; avoid body contact with unwashed items for ≥3 days
Institutional outbreaks: Treat all affected residents/staff, identify index case (often crusted scabies), consider temporary quarantine
First-Line Treatment (Adults & Children ≥6 months)
Permethrin 5% cream (topical) – First-line
Apply to cool, dry skin from neck down (include scalp in infants/elderly/Northern Australia)
Leave 8–12 hrs (overnight), reapply to washed areas, repeat in 7 days
Safe in pregnancy/breastfeeding
Ivermectin (oral) – Alternative or adjunct
200 mcg/kg, with fatty food, repeat in 7 days
Useful in large outbreaks, crusted scabies, poor adherence to topical treatment
Not for children <15 kg, pregnancy/breastfeeding
Alternative Treatments
Benzyl benzoate 25% (topical) – Irritating, less preferred
Crotamiton 10% or Sulfur ointment – Alternative in infants <6 months
Post-Scabies Itch
Can persist ≥3 weeks after treatment → use moderate-potency topical corticosteroids
Persistent nodules → may need intralesional corticosteroid injection
Special Considerations
Infants <6 months
Permethrin 5% recommended despite no official registration (serious morbidity if untreated)
Apply whole body (including head/neck, avoiding eyes/mucosa)
Cover hands to prevent ingestion, repeat in 7 days
Crusted (Norwegian) Scabies
Highly infectious, requires urgent expert consultation (Infectious Diseases/Dermatology)
Combination therapy:
Multiple oral ivermectin doses (days 1, 2, 8, 9, 15 ± extended course)
Topical permethrin every second day initially
Keratolytic agent (e.g., 5–10% salicylic acid) to enhance penetration
Empirical antibiotics (secondary bacterial infection common)
Isolation/contact precautions in institutions until treated
Bookmark Failed!
Bookmark Saved!